Zhejiang CONBA Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2021: 0.02%

Zhejiang CONBA Pharmaceutical Co Ltd (600572) has an Asset Resilience Ratio of 0.02% as of March 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang CONBA Pharmaceutical Co Ltd (600572) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.80 Million

≈ $262.70K USD Cash + Short-term Investments

Total Assets

CN¥8.92 Billion

≈ $1.31 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2020)

This chart shows how Zhejiang CONBA Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 600572 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang CONBA Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang CONBA Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.80 Million	0.02%
Total Liquid Assets	CN¥1.80 Million	0.02%

Asset Resilience Insights

Limited Liquidity: Zhejiang CONBA Pharmaceutical Co Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang CONBA Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang CONBA Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for Zhejiang CONBA Pharmaceutical Co Ltd (2001–2020)

The table below shows the annual Asset Resilience Ratio data for Zhejiang CONBA Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	0.02%	CN¥1.80 Million ≈ $262.70K	CN¥9.28 Billion ≈ $1.36 Billion	-0.11pp
2019-12-31	0.13%	CN¥13.04 Million ≈ $1.91 Million	CN¥9.86 Billion ≈ $1.44 Billion	-0.38pp
2018-12-31	0.51%	CN¥54.87 Million ≈ $8.03 Million	CN¥10.71 Billion ≈ $1.57 Billion	-1.02pp
2017-12-31	1.53%	CN¥144.02 Million ≈ $21.07 Million	CN¥9.42 Billion ≈ $1.38 Billion	+0.69pp
2016-12-31	0.84%	CN¥71.48 Million ≈ $10.46 Million	CN¥8.50 Billion ≈ $1.24 Billion	+0.01pp
2015-12-31	0.83%	CN¥79.23 Million ≈ $11.59 Million	CN¥9.57 Billion ≈ $1.40 Billion	+0.74pp
2014-12-31	0.09%	CN¥5.50 Million ≈ $804.82K	CN¥6.30 Billion ≈ $921.72 Million	+0.08pp
2008-12-31	0.00%	CN¥64.05K ≈ $9.37K	CN¥1.57 Billion ≈ $229.63 Million	-0.06pp
2007-12-31	0.06%	CN¥935.55K ≈ $136.90K	CN¥1.55 Billion ≈ $226.53 Million	+0.04pp
2006-12-31	0.02%	CN¥240.44K ≈ $35.18K	CN¥1.26 Billion ≈ $183.77 Million	+0.00pp
2005-12-31	0.01%	CN¥171.72K ≈ $25.13K	CN¥1.16 Billion ≈ $169.10 Million	0.00pp
2004-12-31	0.02%	CN¥167.78K ≈ $24.55K	CN¥981.41 Million ≈ $143.61 Million	-0.01pp
2003-12-31	0.03%	CN¥174.31K ≈ $25.51K	CN¥581.65 Million ≈ $85.11 Million	-0.03pp
2002-12-31	0.06%	CN¥269.97K ≈ $39.51K	CN¥462.63 Million ≈ $67.70 Million	-0.21pp
2001-12-31	0.27%	CN¥1.22 Million ≈ $178.61K	CN¥447.63 Million ≈ $65.50 Million	--

pp = percentage points

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.65 Billion

CN¥11.29 Billion CNY

Market Cap Rank

#7028 Global

#1646 in China

Share Price

CN¥4.45

Change (1 day)

-0.67%

52-Week Range

CN¥4.06 - CN¥4.94

All Time High

CN¥10.42